Literature DB >> 1942216

Typhoid fever in Singapore: a review of 370 cases.

F S Yew1, S K Chew, K T Goh, E H Monteiro, Y S Lim.   

Abstract

The medical records of 370 patients treated for typhoid fever between 1986 and 1988 at the Communicable Disease Centre, Singapore, were reviewed. The disease was generally mild. There was no mortality. Fever was found in 98.4% of patients on admission and diarrhoea in 21%. Cough was predominantly a symptom of children and occurred in 7.1% of patients aged below 15 years. Other symptoms were uncommon. Hepatomegaly was found in 71% and splenomegaly in 47%. Leucopenia was not a helpful diagnostic marker. Chloramphenicol was the drug of choice. The relapse rate was 5.4% and the convalescent and temporary carrier rates 11.6%. The risk of developing the carrier state was significantly higher among patients who were afebrile on admission compared with those who were febrile (P less than 0.001); it was also higher in patients treated with ampicillin as compared to those treated with chloramphenicol (P less than 0.001, chi 2 = 22.7, odds ratio = 5.25, 95% confidence limits: 2.46 and 11.29). The role of ampicillin as a first line treatment for acute typhoid fever may need further re-evaluation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1942216

Source DB:  PubMed          Journal:  J Trop Med Hyg        ISSN: 0022-5304


  10 in total

1.  Epidemiology and control of an outbreak of typhoid in a psychiatric institution.

Authors:  K T Goh; S H Teo; L Tay; E H Monteiro
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

2.  Outbreak of typhoid fever in vaccinated members of the French Armed Forces in the Ivory Coast.

Authors:  Rémy Michel; Eric Garnotel; André Spiegel; Marc Morillon; Pierre Saliou; Jean-Paul Boutin
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  Epidemiology of typhoid fever in Singapore.

Authors:  F S Yew; K T Goh; Y S Lim
Journal:  Epidemiol Infect       Date:  1993-02       Impact factor: 2.451

4.  Dissemination of persistent intestinal bacteria via the mesenteric lymph nodes causes typhoid relapse.

Authors:  Amanda J Griffin; Lin-Xi Li; Sabrina Voedisch; Oliver Pabst; Stephen J McSorley
Journal:  Infect Immun       Date:  2011-01-24       Impact factor: 3.441

5.  Splenomegaly in 2,505 patients in a large university medical center from 1913 to 1995. 1913 to 1962: 2,056 patients.

Authors:  R A O'Reilly
Journal:  West J Med       Date:  1998-08

6.  Early eradication of persistent Salmonella infection primes antibody-mediated protective immunity to recurrent infection.

Authors:  Tanner M Johanns; Calvin Y Law; Lokeshchandra A Kalekar; Hope O'Donnell; James M Ertelt; Jared H Rowe; Sing Sing Way
Journal:  Microbes Infect       Date:  2010-12-04       Impact factor: 2.700

Review 7.  Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda.

Authors:  A J Griffin; S J McSorley
Journal:  Mucosal Immunol       Date:  2011-02-09       Impact factor: 7.313

8.  Salmonella enterica serovar Typhi-specific immunoglobulin A antibody responses in plasma and antibody in lymphocyte supernatant specimens in Bangladeshi patients with suspected typhoid fever.

Authors:  Alaullah Sheikh; M Saruar Bhuiyan; Farhana Khanam; Fahima Chowdhury; Amit Saha; Dilruba Ahmed; K M A Jamil; Regina C LaRocque; Jason B Harris; Mian Mashhud Ahmad; Richelle Charles; W Abdullah Brooks; Stephen B Calderwood; Alejandro Cravioto; Edward T Ryan; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2009-09-09

9.  Enteric Fever in asir region, southern of saudi arabia.

Authors:  G M Malik
Journal:  J Family Community Med       Date:  1994-01

Review 10.  Spatial and Temporal Patterns of Typhoid and Paratyphoid Fever Outbreaks: A Worldwide Review, 1990-2018.

Authors:  Samuel Kim; Kang Sung Lee; Gi Deok Pak; Jean-Louis Excler; Sushant Sahastrabuddhe; Florian Marks; Jerome H Kim; Vittal Mogasale
Journal:  Clin Infect Dis       Date:  2019-10-30       Impact factor: 9.079

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.